Teva UK introduces first generic oral anticoagulant
Apixaban will be available for the prevention of stroke and deep vein thrombosis
Read More
Author: Iona Everson
NICE recommends UCB’s Fintepla for Dravet syndrome
The drug is used to treat seizures caused by this rare syndrome that is a form of epilepsy
Read More
Catalent acquires Oxfordshire facility to expand biologics in UK and Europe
The biologics development and manufacturing facility is currently under construction near Oxford, UK
Read More
NICE overturns previous decision, recommends Merck and Pfizer’s Bavencio
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
Read More
NICE recommends Koselugo for the treatment of neurofibromatosis type 1
Alexion Pharma UK, AstraZeneca’s Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment
Read More- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
